Antibacterial activity of allicin alone and in combination with β-lactams against Staphylococcus spp. and Pseudomonas aeruginosa

Journal of Antibiotics

Volumn 60, Issue 5, 2007, Pages 335-338

  Cai, Yun ^a   Wang, Rui ^a   Pei, Fei ^a   Liang, Bei Bei ^a  

^a CHINESE PLA GENERAL HOSPITAL   (China)

Author keywords

Allicin; Cefazolin; Cefoperazone; Oxacillin; Synergy

Indexed keywords

ALLICIN; CEFAZOLIN; CEFOPERAZONE; OXACILLIN; ANTIINFECTIVE AGENT; BETA LACTAM; SULFINIC ACID DERIVATIVE;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; DILUTION; DRUG POTENTIATION; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS AUREUS; STAPHYLOCOCCUS EPIDERMIDIS; DRUG EFFECT; LETTER; MICROBIOLOGICAL EXAMINATION; STAPHYLOCOCCUS;

ALLIUM SATIVUM; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS;

ANTI-BACTERIAL AGENTS; BETA-LACTAMS; CEFAZOLIN; CEFOPERAZONE; DRUG SYNERGISM; MICROBIAL SENSITIVITY TESTS; OXACILLIN; PSEUDOMONAS AERUGINOSA; STAPHYLOCOCCUS; SULFINIC ACIDS;

EID: 34548454935     PISSN: 00218820     EISSN: None     Source Type: Journal    
DOI: 10.1038/ja.2007.45     Document Type: Article

References (23)

1. Bosso JA. The antimicrobial armamentarium: evaluating current and future treatment options. Pharmacotherapy 25: 55S-62S (2005)
2. Combes A, Luyt CE, Trouillet JL. Impact of antibiotic-resistant bacteria on the outcome of ventilator-associated pneumonia. Semin Respir Crit Care Med 27: 23-28 (2006)
3. Hauser AR, Sriram P. Severe Pseudomonas aeruginosa infections. Tackling the conundrum of drug resistance. Postgrad Med 117: 41-48 (2005)
4. Maltezou HC, Giamarellou H. Community-acquired methicillin-resistant Staphylococcus aureus infections. Int J Antimicrob Agents 27: 87-96 (2006)
5. Nick JA, Rodman DM. Manifestations of cystic fibrosis diagnosed in adulthood. Curr Opin Pulm Med 11: 513-518 (2005)
6. Obritsch MD, Fish DN, MacLaren R, Jung R. Nosocomial infections due to multidrug-resistant Pseudomonas aeruginosa: epidemiology and treatment options. Pharmacotherapy 25: 1353-1364 (2005)
7. George M, Eliopoulos, Robert C, Moellering JR. Antimicrobial Combinations. Antibiotics in Laboratory Medicine 4th ed. pp. 330, The Williams & Wilkins Co., Baltimore (1996)
8. Adetumbi MA, Lau BH. Allium sativum (garlic) - a natural antibiotic. Med Hypotheses 12: 227-237 (1983)
9. Bakri IM, Douglas CW. Inhibitory effect of garlic extract on oral bacteria. Arch Oral Biol 50: 645-651 (2005)
10. Cutler RR, Wilson P. Antibacterial activity of a new, stable, aqueous extract of allicin against methicillin-resistant Staphylococcus aureus. Br J Biomed Sci 61: 71-74 (2004)
11. Kabelik J. Antimicrobial properties of garlic. Pharmazie 25: 266-270 (1970)
12. Ankri S, Mirelman D. Antimicrobial properties of allicin from garlic. Microbes Infect 1: 125-129 (1999)
13. Sahm DF, Washington II JA. Antibacterial susceptibility tests: dilution methods. Manual of clinical microbiology 6th ed. pp. 1117, American Society for Microbiology, Washington DC (1995)
14. Iwalokun BA, Ogunledun A, Ogbolu DO, Bamiro SB, Jimi-Omojola J. In vitro antimicrobial properties of aqueous garlic extract against multidrug-resistant bacteria and Candida species from Nigeria. J Med Food 7: 327-333 (2004)
15. Maldonado PD, Chanez-Cardenas ME, Pedraza-Chaverri J. Aged garlic extract, garlic powder extract, S-allylcysteine, diallyl sulfide and diallyl disulfide do not interfere with the antibiotic activity of gentamicin. Phytother Res 19: 252-254 (2005)
16. Perez-Giraldo C, Cruz-Villalon G, Sanchez-Silos R, Martinez-Rubio R, Blanco MT, Gomez-Garcia AC. In vitro activity of allicin against Staphylococcus epidermidis and influence of subinhibitory concentrations on biofilm formation. J Appl Microbiol 95: 709-711 (2003)
17. Persson T, Hansen TH, Rasmussen TB, Skinderso ME, Givskov M, Nielsen J. Rational design and synthesis of new quorum-sensing inhibitors derived from acylated homoserine lactones and natural products from garlic. Org Biomol Chem 3: 253-262 (2005)
18. Rossolini GM, Mantengoli E. Treatment and control of severe infections caused by multiresistant Pseudomonas aeruginosa. Clin Microbiol Infect 11: 17-32 (2005)
19. Elnima EI, Ahmed SA, Mekkawi AG, Mossa JS. The antimicrobial activity of garlic and onion extracts. Pharmazie 38: 747-748 (1983)
20. Ruddock PS, Liao M, Foster BC, Lawson L, Arnason JT, Dillon JA. Garlic natural health products exhibit variable constituent levels and antimicrobial activity against Neisseria gonorrhoeae, Staphylococcus aureus and Enterococcus faecalis. Phytother Res 19: 327-334 (2005)
21. Schmidt-Ioanas M, de Roux A, Lode H. New antibiotics for the treatment of severe staphylococcal infection in the critically ill patient. Curr Opin Crit Care 11: 481-486 (2005)
22. Tsao S, Yin M. In vitro activity of garlic oil and four diallyl sulphides against antibiotic-resistant Pseudomonas aeruginosa and Klebsiella pneumoniae. J Antimicrob Chemother 47: 665-670 (2001)
23. Bjarnsholt T, Jensen PO, Rasmussen TB, Christophersen L, Calum H, Hentzer M, Hougen HP, Rygaard J, Moser C, Eberl L, Hoiby N, Givskov M. Garlic blocks quorum sensing and promotes rapid clearing of pulmonary Pseudomonas aeruginosa infections. Microbiology 151: 3873-3880 (2005)